documents: FDA-2025-N-4684-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2025-N-4684-0001 FDA FDA-2025-N-4684 Egis Pharmaceuticals Limited, et.al.; Proposal To Withdraw Approval of Three Abbreviated New Drug Applications; Opportunity for a Hearing Notice Withdrawal 2025-12-29T05:00:00Z 2025 12 2025-12-29T05:00:00Z 2026-02-28T04:59:59Z 2025-12-29T19:49:40Z 2025-23870 0 0 09000064b910a3d3

Links from other tables